In September 2020, Biotech Pharma enters into a licensing arrangement with Clover Pharmaceuticals for a drug under development that gives Clover to the right to use Biotechs patent to manufacture and sell the drug under the license given by Biotech Pharma. Biotech will receive a payment of $25,000,000 if the drug is approved by FDA. Based on past experience in drug approval process, Biotech determines that it is 80% likely that the drug will gain approval with 20% change of denial.

1. Determine the transaction price of the revenue arrangement for Biotech and prepare journal entries for Biotech on December 10, 2020 and January 31, 2021.